• SENSEX 76,520.97
    496.46 (+0.65%)
  • BANKNIFTY 50,827.50
    -737.35 (--1.43%)
  • IndusInd Bank
    708.45 1,576.00(%)
  • Dr Lal Pathlabs
    2,494.00 3,645.00(%)
  • ICICI BLR Growth
    1,003.14 1,001.47(%)
  • Vodafone Idea
    8.33 19.15(%)
  • Bharat Electron
    274.50 204.00(%)
  • Kalyan Jewellers
    503.80 794.60(%)
  • Quadrant Future
    605.00 743.45(%)
  • SRF
    2,971.10 3,074.95(%)
  • Zomato Ltd
    210.60 304.50(%)
  • SpiceJet
    46.10 79.90(%)
  • ICICI Bank
    1,338.00 1,372.50(%)
  • Mazagon Dock
    2,601.00 2,929.98(%)
  • Aegis Logistics
    830.35 1,035.70(%)
  • Dixon Technolog.
    13,471.75 19,149.80(%)
  • Adani Green
    944.45 2,173.65(%)
  • M & M
    2,627.00 1,891.30(%)
  • Suzlon Energy
    56.95 86.04(%)
  • Hind.Aeronautics
    4,252.00 5,675.00(%)
  • Tata Motors
    662.00 606.20(%)
  • Nippon ETF Liq.
    999.99 996.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Glaxosmithkline Pharmaceuticals Ltd Pharmaceuticals - Multinational

  • MNC Asc-Glaxo
  • BSE Code : 195.0
  • ISIN : INE159A01016
2,797.35 -83 (-2.88%)
  • As on 02 Apr 2025 (EOD)

  • Today’s Low

    2,777.00

  • Today’s High

    2,878.00

  • Open

    2,872.00

  • Perv Close

    2,880.35

  • 52W Low

    1,842.05

  • 52W High

    3,088.00

Key Indicators

  • P/E(TTM)

    55.88

  • Mar.Cap (₹Cr.)

    47,388.80

  • Div & Yield %

    1.15

  • Book Value(₹)

    98.85

  • Debt-Equity Ratio

    -2.88

  • AGM Date

    01-Apr-2025

  • EPS

    49.99

  • P/E Ratio

    55.88

Financials Ratios

  • Debt-Equity Ratio

    0.01

  • Mar.Cap (₹Cr.)

    47,388.80

  • RONW (%)

    37.32

  • ROCE (%)

    44.97

Score Board

  • Equity (₹ in Cr.)

    169.41

  • BV (₹)

    98.90

  • Sales( ₹ in Cr.)

    3,407.25

  • NP (in Cr.)

    651.27

  • NP Var(%)

    11.0

  • Div%

    320.0

  • CPS (₹)

    42.60

  • EPS (₹)

    38.40

  • Traded Value (₹ in Lakhs)

    47,321.88

  • 52 Week High

    3,088.00

  • 52 Week Low

    1,842.05

  • Price BSE

    2793.0

  • Price NSE

    2,797.00

  • Market Capital( in Cr.)

    47,321.88

  • P/C Ratio

    65.60

  • P/E Ratio

    72.70

  • Price Vs.BV

    38.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 3,407.25 3,216.34 3,217.51 2,920.48 3,224.68 3,128.53
Excise Duty 3,385.94 3,181.40 3,190.08 2,886.42 3,187.35 3,089.48
Net Sales 3,407.25 3,216.34 3,217.51 2,920.48 3,224.68 3,128.53
Other Income 123.48 101.51 76.22 110.19 77.56 101.48
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 3,530.73 3,317.86 3,293.72 3,030.66 3,302.24 3,230.01
EXPENDITURE :
Raw Materials 3,385.94 3,181.40 3,190.08 2,886.42 3,187.35 3,089.48
Power & Fuel Cost 3,385.94 3,181.40 3,190.08 2,886.42 3,187.35 3,089.48
Employee Cost 624.39 594.99 610.23 616.16 628.55 537.20
Other Manufacturing Expenses 75.82 72.95 64.17 78.51 111.89 106.88
Selling & Administrative Expenses 374.71 370.30 343.57 242.00 376.68 381.32
Miscellaneous Expenses 75.82 72.95 64.17 78.51 111.89 106.88
Less : Pre-operative Expenses Capitalised :
Total Expenditure 2,578.08 2,484.50 2,531.86 2,404.84 2,655.24 2,571.20
Operating Profit 143.25 128.65 147.97 136.66 141.24 143.13
Interest 1.80 1.81 1.99 3.53 6.34 0.55
Gross Profit 809.04 832.39 773.44 453.23 322.50 663.71
Depreciation 69.68 65.77 68.19 78.60 82.68 48.59
Profit Before Tax 809.04 832.39 773.44 453.23 322.50 663.71
Tax 235.71 246.05 219.43 158.67 235.31 192.82
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -11.36 -18.37 -10.49 7.87 -47.72 45.52
Reported Net Profit 584.69 604.71 376.58 286.69 110.05 425.36
Extraordinary Items 809.04 832.39 773.44 453.23 322.50 663.71
Adjusted Net Profit 584.69 604.71 376.58 286.69 110.05 425.36
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 4.13 1,708.18 96.51 0.00 0.00
Statutory Appropriations 542.13 542.13 1,524.74 508.25 677.62 338.81
P & L Balance carried down 584.69 604.71 376.58 286.69 110.05 425.36
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 320.00 320.00 900.00 300.00 400.00 200.00
Dividend Per Share(Rs) 32.00 32.00 90.00 30.00 40.00 20.00
Earnings Per Share-Unit Curr 34.51 35.88 99.79 21.11 6.50 25.11
Book Value 542.13 542.13 1,524.74 508.25 677.62 338.81
Book Value(Adj)-Unit Curr 542.13 542.13 1,524.74 508.25 677.62 338.81

Shareholding Pattern

  • Promoter Group

    75.00%

  • Public Share Holding

    25.00%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 127,054,524 75.00 127,054,524 4
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 127,054,524 75.00 127,054,524 4
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 8,006 0.00 8,006 3
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 22,328 0.01 15,364 18
Foreign Bank 1,849 0.00 1,811 3
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 7,624,102 4.50 7,624,102 255
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 3,776,804 2.23 3,776,804 12
Mutual Funds / UTI 8,408,346 4.96 8,394,926 35
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 162,124 0.10 149,240 21
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 20,003,559 11.81 19,970,253 347
2] Non Institution
Bodies Corporate 1,365,505 0.81 1,349,717 871
Clearing Members 600 0.00 600 7
Directors of their Relatives 600 0.00 600 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 788,864 0.47 777,611 3,569
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 422,550 0.25 422,550 2,347
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 808,659 0.48 808,659 18
Individuals holding nominal share capital up to Rs. 1 lakh 17,764,475 10.49 16,543,220 112,427
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 132,524 0.08 132,524 33
Others 1,064,174 0.63 1,064,174 1
Sub Total 22,347,951 13.19 21,099,655 119,274
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 169,406,034 100.00 168,124,432 119,625

Company Background

Glaxosmithkline Pharmaceuticals LtdPharmaceuticals - Multinational

  • Glaxosmithkline Pharmaceuticals Ltd
  • BSE Code : 195.0
  • ISIN : INE159A01016

  • Incorporation Year

    1924

  • Registered Office

    GSK House
    Dr Annie Besant Road Worli, Mumbai,
    Maharashtra-400030

  • Telephone

    91-022-24959595

  • FAX

    91-022-24959494

  • Chairman

    Renu S Karnad

  • Managing Director

    Bhushan Akshikar

  • Company Secretary

    A A Nadkarni

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Glaxosmithkline Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Glaxosmi. Pharma 2,793.40 3,530.73 3,407.25 55.55 44.44
Abbott India 30,305.85 6,097.18 5,848.91 48.26 44.71
Astrazeneca Phar 8,518.55 1,330.33 1,295.53 219.61 33.26
P & G Health Ltd 5,152.30 1,166.89 1,151.26 36.15 39.76
Cipla 1,444.55 17,645.00 16,574.34 24.77 20.10
Novartis India 807.65 396.75 335.07 23.12 15.57
Amrutanjan Healt 642.85 437.58 421.23 37.68 20.84
Fermenta Biotec. 285.30 315.24 307.09 27.04 4.10
Guj. Themis Bio. 271.85 174.19 169.82 56.28 44.82
Bliss GVS Pharma 119.25 638.96 605.46 27.29 11.19
Ambalal Sarabhai 36.15 11.70 3.81 15.45 1.92